- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01866228
Clinical Trial of the Impact of Treatment Consultation Recordings on Cancer Patient Outcomes
February 19, 2018 updated by: Dr. Tom Hack, University of Manitoba
Impact of Treatment Consultation Recordings on Cancer Patient Outcomes: A Prospective, Parallel, Randomized Controlled Trial
The time period from diagnosis through to the end of treatment is challenging for patients.
Patients need information, assistance with decision making, and emotional and social support to help cope with their diagnosis and treatment.
The first meeting with the cancer doctor is especially anxiety-provoking for patients who will learn, for the first time, their treatment options and likelihood of being cured.
This anxiety causes many patients to have difficulty remembering the important pieces of information that their cancer doctor tells them during this consultation.
The main goal of this study is to demonstrate the benefits of giving cancer patients an audio-recording of their first consultation with their cancer doctor.
The investigators will include newly diagnosed patients from cancer centres in Winnipeg and Calgary.
The types of cancer that will be included in this study are brain and neuroendocrine.
Patients with these types of cancer are more likely to have confused thinking, and therefore may have the most to gain from receiving their consultation recordings.
The study will include 244 patients, and those who sign consent forms to participate will be assigned by chance to either receive their treatment consultation recording or not.
Patients will receive their recording immediately after their consultation, and will be able to listen to the recording at any time either alone, or with family and friends.
To figure out whether the consultation recording provides patients with benefits, the investigators will administer some questionnaires to patients at 1 week after the consultation, and again at 3 and 6 months after the consultation.
These questionnaires will assess the following patient outcomes: i) anxiety and depression, ii) perception of being informed about the disease and treatment, iii) satisfaction with cancer care, iv) satisfaction with the doctor, and v) the extent to which patients are satisfied with their degree of involvement in treatment decision making.
The investigators hypothesize that patients who receive their consultation recording will experience more benefits than patients who do not receive their consultation recording.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
140
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alberta
-
Calgary, Alberta, Canada, T2N 4N2
- Tom Baker Cancer Centre
-
-
British Columbia
-
Vancouver, British Columbia, Canada
- British Columbia Cancer Agency
-
-
Manitoba
-
Winnipeg, Manitoba, Canada, R3E 0V9
- Cancer Care Manitoba
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- presenting with a primary diagnosis of non-recurrent or metastatic brain, or neuroendocrine cancer
- 18 years of age or older
- able to read and communicate using the English language
- access to a computer to enable consultation playback
Exclusion Criteria:
- deemed by a treating clinician (or primary nurse for the treating clinician) to have any severe psychiatric condition or cognitive dysfunction that precludes provision of free and informed consent to participate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: No Consultation Recording
Participant does not receive consultation recording
|
|
Experimental: Consultation Recording
Participant receives consultation recording
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline in Control Preferences Scale at 1-week post-consultation
Time Frame: 1-week post-consultation
|
Subjective report of actual role played in decision making.
|
1-week post-consultation
|
Change from Baseline in Control Preferences Scale at 3-months post-consultation
Time Frame: 3-months post-consultation
|
Subjective report of actual role played in decision making.
|
3-months post-consultation
|
Change from Baseline in Control Preferences Scale at 6-months post-consultation
Time Frame: 6-months post-consultation
|
Subjective report of actual role played in decision making.
|
6-months post-consultation
|
Change from Baseline in Patient Satisfaction with Cancer Care Scale at 1-week post-consultation
Time Frame: 1-week post-consultation
|
1-week post-consultation
|
|
Change from Baseline in Patient Satisfaction with Cancer Care Scale at 3-months post-consultation
Time Frame: 3-months post-consultation
|
3-months post-consultation
|
|
Change from Baseline in Patient Satisfaction with Cancer Care Scale at 6-months post-consultation
Time Frame: 6-months post-consultation
|
6-months post-consultation
|
|
Change from Baseline in PrestMan Satisfaction with Doctor Scale at 1-week post-consultation
Time Frame: 1-week post-consultation
|
1-week post-consultation
|
|
Change from Baseline in PrestMan Satisfaction with Doctor Scale at 3-months post-consultation
Time Frame: 3-months post-consultation
|
3-months post-consultation
|
|
Change from Baseline in PrestMan Satisfaction with Doctor Scale at 6-months post-consultation
Time Frame: 6-months post-consultation
|
6-months post-consultation
|
|
Change from Baseline in Hospital Anxiety and Depression Scale at 1-week post-consultation
Time Frame: 1-week post-consultation
|
1-week post-consultation
|
|
Change from Baseline in Hospital Anxiety and Depression Scale at 3-months post-consultation
Time Frame: 3-months post-consultation
|
3-months post-consultation
|
|
Change from Baseline in Hospital Anxiety and Depression Scale at 6-months post-consultation
Time Frame: 6-months post-consultation
|
6-months post-consultation
|
|
Change from Baseline in Perception of Being Informed Scale at 1-week post-consultation
Time Frame: 1- week post-consultation
|
1- week post-consultation
|
|
Change from Baseline in Perception of Being Informed Scale at 3-months post-consultation
Time Frame: 3-months post-consultation
|
3-months post-consultation
|
|
Change from Baseline in Perception of Being Informed Scale at 6-months post-consultation
Time Frame: 6-months post-consultation
|
6-months post-consultation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Thomas F Hack, PhD, University of Manitoba
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2013
Primary Completion (Actual)
February 1, 2017
Study Completion (Actual)
December 1, 2017
Study Registration Dates
First Submitted
April 16, 2013
First Submitted That Met QC Criteria
May 27, 2013
First Posted (Estimate)
May 31, 2013
Study Record Updates
Last Update Posted (Actual)
February 20, 2018
Last Update Submitted That Met QC Criteria
February 19, 2018
Last Verified
February 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Neoplasms by Histologic Type
- Neoplasms
- Neoplasms by Site
- Adenocarcinoma
- Carcinoma
- Neoplasms, Glandular and Epithelial
- Neuroectodermal Tumors
- Neoplasms, Germ Cell and Embryonal
- Neoplasms, Nerve Tissue
- Central Nervous System Neoplasms
- Nervous System Neoplasms
- Neuroendocrine Tumors
- Brain Neoplasms
- Carcinoma, Neuroendocrine
Other Study ID Numbers
- H2013:085
- 126049 (Other Grant/Funding Number: Canadian Institutes of Health Research/126049)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Brain Tumor
-
University of California, San FranciscoGilead SciencesSuspendedBrain Cancer | Malignant Brain Tumor | Brain Tumor Adult | Recurrent Brain Tumor | Progressive Malignant Brain Tumor | Brain Tumor, PediatricUnited States
-
Xinhua Hospital, Shanghai Jiao Tong University...CNOG-MC001 Collaborative GroupCompletedPediatric Brain Tumor | Malignant Brain Tumor | Tumors, Central Nervous System | Benign Brain TumorChina
-
University of Erlangen-Nürnberg Medical SchoolNot yet recruitingBrain Tumor, Primary | Brain Tumor - MetastaticGermany
-
University of NebraskaRecruitingPrimary Brain Tumor | Metastatic Brain TumorUnited States
-
Technical University of MunichRecruiting
-
GT Medical Technologies, Inc.RecruitingBrain Tumor | Brain Tumor, Recurrent | Brain Tumor, Primary | Brain Tumor - Metastatic | Brain Tumor, Adult: Glioblastoma | Brain Tumor, Adult MeningiomaUnited States
-
Washington University School of MedicineNot yet recruitingBrain Tumor, PrimaryUnited States
-
The Hospital for Sick ChildrenPediatric Oncology Group of OntarioCompletedChildhood Brain TumorCanada
-
Ohio State University Comprehensive Cancer CenterCompletedAdult Brain TumorUnited States
-
Lawson Health Research InstituteCompletedBrain Tumor | Brain Neoplasm | Tumor, Brain | Neoplasm, Supratentorial | Tumor, SupratentorialCanada
Clinical Trials on Consultation Recording
-
University of California, San FranciscoConquer Cancer FoundationActive, not recruitingProstate Cancer | Metastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Duke UniversityNational Cancer Institute (NCI)TerminatedNewly Diagnosed Cancer Patients Who Are HIV Positive and Their Treating OncologistUnited States
-
University of UtahHuntsman Cancer InstituteTerminated
-
Centre d'Investigation Clinique et Technologique...National Research Agency, FranceCompletedAttitude to ComputersFrance
-
Centre Hospitalier Universitaire de NiceCompleted
-
University of Southern DenmarkUniversity of Copenhagen; University of Aarhus; Region North DenmarkCompletedQuality of Life | Life StyleDenmark
-
Vastra Gotaland RegionNot yet recruitingOsteoarthritis, Knee | Osteoarthritis, Hip
-
Universidade do PortoCompletedTrapezius Muscle StrainPortugal
-
University of Southern DenmarkOdense University Hospital; Sygekassernes Helsefond; Danish Nurses OrganisationCompleted
-
NewPace LtdCompletedArrhythmias, Cardiac | TachyarrhythmiaUnited States